+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07898475

Lab Study on Fungal Sensitivity to Terbinafine and Itraconazole in Patients with Dermatophytosis at Faisalabad Medical University

Led by Dr. Amara Safdar · Updated on 2026-10-27

120

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates dermatophyte infections, which affect the skin, hair, and nails, in patients from Faisalabad, Pakistan. The study focuses on how these fungi respond to two antifungal drugs, terbinafine and itraconazole, by examining samples from dermatology outpatients with confirmed infections. It aims to identify the proportion of Trichophyton fungi showing elevated sensitivity levels to terbinafine, describe the drug susceptibility patterns, and explore links between these patterns and clinical factors like disease duration and prior medication use. Participants provide skin scrapings, hair, or nail samples that are cultured in a laboratory to grow the fungi. Each fungal isolate is tested against terbinafine and itraconazole using a standardized broth microdilution method to measure how much of each drug is needed to inhibit fungal growth. No treatments are given as part of the study it only involves laboratory testing on collected samples. Data on patient demographics, clinical details, and prior antifungal or corticosteroid use are also recorded. During the study, clinical and laboratory data are gathered and analyzed to assess drug susceptibility and fungal species distribution. The main outcome is the percentage of Trichophyton isolates with higher terbinafine minimum inhibitory concentrations MICs. Secondary outcomes include detailed MIC distributions for both drugs and the relationship between drug sensitivity and patient clinical features. Participation does not affect the patients treatment, and the study is expected to complete by May 2027.

CONDITIONS

Brief Title

In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan

Research Team

K

Kalsoom Jawaid, MBBS, FCPS, CMT

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here